speb/financial-data huggingface dataset:
BCVN.SW balance_sheet (annual, 2022-12-31) — Payables: 11000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Pretax Income: 448600000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Properties: 278000000.00
BCVN.SW cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
BCVN.SW cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
BCVN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -54000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Receivables: 70000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 70000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Rent And Landing Fees: 23900000.00
BCVN.SW cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -24000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 2942000000.00
BCVN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 2000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 17500000.00
BCVN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 19800000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 86061900.00
BCVN.SW income_statement (annual, 2022-12-31) — Special Income Charges: 1200000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3713000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3713000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 156000.00
BCVN.SW income_statement (annual, 2022-12-31) — Tax Provision: 60600000.00
BCVN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.13
BCVN.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 16000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 59397000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 11655000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 7942000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3713000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 55684000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 11000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: 1200000.00
BCVN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1200000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Trading Securities: 206000000.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 179226.00
BCVN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 14000000.00
BCVN.SW income_statement (annual, 2022-12-31) — Write Off: 0.00
BCVN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 614500000.00
BCVN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 1149900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 36000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 85861714.00
BCVN.SW income_statement (annual, 2023-12-31) — Basic EPS: 5.46
BCVN.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 269000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -82000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 13264000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13264000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Cash Financial: 12602000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -328000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 7000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: -384000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: -314000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3855000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Common Stock Issuance: 23000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Common Stock Payments: -24000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Depreciation: 76000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 76000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 72900000.00
BCVN.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 72900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 426000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 85861714.00
BCVN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 5.46
BCVN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 469200000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Dividend Paid Cfo: -327000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -45000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: -271000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -2000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 500000.00
BCVN.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 1500000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 381000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 5134000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Interest Expense: 376100000.00
BCVN.SW income_statement (annual, 2023-12-31) — Interest Income: 972800000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 12300000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -80000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 7080000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Investments And Advances: 7167000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 23000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 8445000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 104000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
BCVN.SW income_statement (annual, 2023-12-31) — Minority Interests: 0.00
BCVN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
BCVN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income: 469200000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 469200000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 469800000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 469200000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 469200000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 469000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 469200000.00
BCVN.SW income_statement (annual, 2023-12-31) — Net Interest Income: 596700000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -44000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 381000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -80000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3855000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Normalized Income: 467566000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: -189000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 1149900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 85888590.00
BCVN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: -23000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 128500000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Other Properties: 8000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Other Special Charges: -1900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Payables: 34000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Pretax Income: 544000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Properties: 269000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 2000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
BCVN.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: -82000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Receivables: 122000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 76000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Rent And Landing Fees: 29800000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -24000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: 3084000000.00
BCVN.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 2000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 17700000.00
BCVN.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 19200000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Share Issued: 86061900.00
BCVN.SW income_statement (annual, 2023-12-31) — Special Income Charges: 1900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3855000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3855000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 266000.00
BCVN.SW income_statement (annual, 2023-12-31) — Tax Provision: 74200000.00
BCVN.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.14
BCVN.SW balance_sheet (annual, 2023-12-31) — Taxes Receivable: 15000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Assets: 58870000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: 12300000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Debt: 8445000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3855000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 55015000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Total Tax Payable: 34000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Total Unusual Items: 1900000.00
BCVN.SW income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1900000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Trading Securities: 229000000.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 173310.00
BCVN.SW balance_sheet (annual, 2023-12-31) — Treasury Stock: 14000000.00
BCVN.SW income_statement (annual, 2023-12-31) — Write Off: 0.00
BCVN.SW income_statement (annual, 2024-12-31) — +Operating Expense: 629100000.00
BCVN.SW income_statement (annual, 2024-12-31) — +Total Revenue: 1139900000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -460000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -460000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 39000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 39000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 85876073.00
BCVN.SW income_statement (annual, 2024-12-31) — Basic EPS: 5.13
BCVN.SW balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 570000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 570000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -79000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11753000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 11753000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 11753000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 11753000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Cash Financial: 10614000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Cash Financial: 10614000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -336000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Change In Receivables: -81000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: 4419000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Changes In Cash: 5566000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Common Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3927000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 3927000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Common Stock Issuance: 29000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Common Stock Payments: -28000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Depreciation: 82000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 82000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 73000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Depreciation Income Statement: 73000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 517000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 517000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Diluted Average Shares: 85876073.00
BCVN.SW income_statement (annual, 2024-12-31) — Diluted EPS: 5.13
BCVN.SW income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 440600000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Dividend Paid Cfo: -370000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Financing Cash Flow: 539000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Free Cash Flow: 5027000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 3000000.00
BCVN.SW income_statement (annual, 2024-12-31) — General And Administrative Expense: 1900000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Gross PPE: 839000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Gross PPE: 839000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 6002000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Held To Maturity Securities: 6002000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Interest Expense: 464500000.00
BCVN.SW income_statement (annual, 2024-12-31) — Interest Income: 1019600000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Invested Capital: 13375000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Invested Capital: 13375000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 8024000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 8024000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Investments And Advances: 8111000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 8111000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 29000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9448000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9448000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 205000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 205000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
BCVN.SW income_statement (annual, 2024-12-31) — Minority Interests: 0.00
BCVN.SW cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
BCVN.SW cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 29000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income: 440600000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 440600000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 440900000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 440600000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 440600000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 441000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 440600000.00
BCVN.SW income_statement (annual, 2024-12-31) — Net Interest Income: 555100000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 510000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Net PPE: 379000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Net PPE: 379000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3927000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 3927000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Normalized Income: 440087126.79
BCVN.SW cash_flow (annual, 2024-12-31) — Operating Cash Flow: 5027000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Operating Revenue: 1139900000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 85909760.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 85909760.00
BCVN.SW cash_flow (annual, 2024-12-31) — Other Non Cash Items: 42000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Other Operating Expenses: 119800000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Other Properties: 64000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Other Properties: 64000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Other Special Charges: -600000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Payables: 35000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Payables: 35000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Pretax Income: 515800000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 43000000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
BCVN.SW cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Receivables: 113000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Receivables: 113000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Reconciled Depreciation: 82000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Rent And Landing Fees: 28800000.00
BCVN.SW cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -28000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Retained Earnings: 3155000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 3155000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 18700000.00
BCVN.SW income_statement (annual, 2024-12-31) — Selling General And Administration: 20600000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Share Issued: 86061900.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Share Issued: 86061900.00
BCVN.SW income_statement (annual, 2024-12-31) — Special Income Charges: 600000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3927000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 3927000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3927000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 3927000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 87126.79
BCVN.SW income_statement (annual, 2024-12-31) — Tax Provision: 74900000.00
BCVN.SW income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
BCVN.SW balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 10000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Assets: 60629000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Assets: 60629000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Capitalization: 13375000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 13375000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Debt: 9448000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Debt: 9448000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3927000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 3927000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 56702000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 56702000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Total Tax Payable: 35000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 35000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Total Unusual Items: 600000.00
BCVN.SW income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 600000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Trading Securities: 317000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Trading Securities: 317000000.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 152140.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 152140.00
BCVN.SW balance_sheet (annual, 2024-12-31) — Treasury Stock: 13000000.00
BCVN.SW balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 13000000.00
BCVN.SW income_statement (annual, 2024-12-31) — Write Off: 0.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 7737000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 10787000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 10787000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Cash Financial: 10053000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Common Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3762000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 552000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Invested Capital: 14054000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 8595000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 8682000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 10292000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Minority Interest: 0.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Net PPE: 365000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3762000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 85909760.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 215000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Receivables: 112000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2776000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 85909760.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3762000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3762000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 61219000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 14054000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Total Debt: 10292000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3762000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 57457000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Trading Securities: 428000000.00
BCVN.SW balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 15000000.00
BCVN.SW income_statement (annual, 2025-12-31) — +Operating Expense: 637500000.00
BCVN.SW income_statement (annual, 2025-12-31) — +Total Revenue: 1134800000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 37000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 37000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 85869789.00
BCVN.SW income_statement (annual, 2025-12-31) — Basic EPS: 5.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 255000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 255000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9366000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9366000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 9366000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 9366000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Cash Financial: 8699000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Cash Financial: 8699000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Change In Receivables: 35000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Change In Working Capital: 5248000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Changes In Cash: 6091000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Common Stock: 86000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 86000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3976000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3976000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Common Stock Issuance: 27000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Depreciation: 82000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 82000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 73400000.00
BCVN.SW income_statement (annual, 2025-12-31) — Depreciation Income Statement: 73400000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 318000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 318000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 85869789.00
BCVN.SW income_statement (annual, 2025-12-31) — Diluted EPS: 5.00
BCVN.SW income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 429700000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: 282000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: 5809000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 800000.00
BCVN.SW income_statement (annual, 2025-12-31) — General And Administrative Expense: 1900000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Gross PPE: 366000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Gross PPE: 366000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 7387000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 7387000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Interest Expense: 250400000.00
BCVN.SW income_statement (annual, 2025-12-31) — Interest Income: 779300000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 15123000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 15123000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 9690000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 9690000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Investments And Advances: 9777000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 9777000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 27000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11147000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11147000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 87000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 93000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 93000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
BCVN.SW income_statement (annual, 2025-12-31) — Minority Interests: 0.00
BCVN.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 27000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Net Debt: 1781000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Net Debt: 1781000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income: 429700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 429700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 429700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 429700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 429700000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 430000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 429700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Net Interest Income: 528900000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 255000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Net PPE: 366000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 366000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3976000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3976000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Normalized Income: 429102720.41
BCVN.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: 5809000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Operating Revenue: 1134800000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 85886651.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 85886651.00
BCVN.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: 14000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Other Operating Expenses: 123200000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Other Properties: 18000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 18000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Other Special Charges: -800000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Payables: 16000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Payables: 16000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Pretax Income: 503600000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 35000000.00
BCVN.SW cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Receivables: 107000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Receivables: 107000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 82000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Rent And Landing Fees: 26500000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: 3206000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3206000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 19200000.00
BCVN.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 21100000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Share Issued: 86061900.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 86061900.00
BCVN.SW income_statement (annual, 2025-12-31) — Special Income Charges: 700000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3976000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3976000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3976000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3976000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 102720.41
BCVN.SW income_statement (annual, 2025-12-31) — Tax Provision: 73900000.00
BCVN.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
BCVN.SW balance_sheet (annual, 2025-12-31) — Taxes Receivable: 11000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 11000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Assets: 61620000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 61620000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 15123000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 15123000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Debt: 11147000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 11147000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3976000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3976000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 57644000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 57644000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 16000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 16000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Total Unusual Items: 700000.00
BCVN.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 700000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Trading Securities: 523000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Trading Securities: 523000000.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 175249.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 175249.00
BCVN.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 16000000.00
BCVN.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 16000000.00
BCVN.SW income_statement (annual, 2025-12-31) — Write Off: 100000.00
BCX balance_sheet (annual, 2021-12-31) — Accounts Payable: 9596324.00
BCX income_statement (annual, 2021-12-31) — Basic Average Shares: 88195626.00
BCX income_statement (annual, 2021-12-31) — Basic EPS: 2.24
BCX income_statement (annual, 2021-12-31) — Diluted Average Shares: 88195626.00
BCX income_statement (annual, 2021-12-31) — Diluted EPS: 2.24
BCX balance_sheet (annual, 2021-12-31) — Invested Capital: 901967826.00
BCX cash_flow (annual, 2021-12-31) — Issuance Of Debt: 185937.00
BCX balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 185937.00
BCX cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 185937.00
BCX balance_sheet (annual, 2021-12-31) — Net Debt: 98092.00
BCX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 0.00
BCX balance_sheet (annual, 2021-12-31) — Total Capitalization: 901967826.00
BCX balance_sheet (annual, 2021-12-31) — Total Debt: 185937.00
BCX income_statement (annual, 2022-12-31) — +Operating Expense: 2700087.00
BCX income_statement (annual, 2022-12-31) — +Total Revenue: 140210842.00
BCX balance_sheet (annual, 2022-12-31) — Accounts Payable: 173520.00
BCX balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 19404102.00
BCX income_statement (annual, 2022-12-31) — Basic Average Shares: 87586468.00
BCX income_statement (annual, 2022-12-31) — Basic EPS: 1.57
BCX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 357845.00
BCX balance_sheet (annual, 2022-12-31) — Capital Stock: 1076105039.00
BCX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 39403.00
BCX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 69403.00
BCX cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -48513774.00
BCX balance_sheet (annual, 2022-12-31) — Cash Financial: 39403.00
BCX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -12835.00
BCX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 0.00
BCX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
BCX cash_flow (annual, 2022-12-31) — Change In Payable: -38637.00
BCX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 0.00
BCX cash_flow (annual, 2022-12-31) — Change In Receivables: 97368.00
BCX cash_flow (annual, 2022-12-31) — Change In Working Capital: 45896.00
BCX cash_flow (annual, 2022-12-31) — Changes In Cash: -287881.00
BCX balance_sheet (annual, 2022-12-31) — Common Stock: 1076105039.00
BCX cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -48513774.00
BCX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 983181040.00
BCX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
BCX cash_flow (annual, 2022-12-31) — Common Stock Payments: -6850455.00
BCX balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 6601706.00
BCX income_statement (annual, 2022-12-31) — Diluted Average Shares: 87586468.00
BCX income_statement (annual, 2022-12-31) — Diluted EPS: 1.57
BCX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 137510755.00
BCX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -561.00
BCX cash_flow (annual, 2022-12-31) — End Cash Position: 69403.00
BCX balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 965979491.00
BCX cash_flow (annual, 2022-12-31) — Financing Cash Flow: -55432583.00
BCX cash_flow (annual, 2022-12-31) — Free Cash Flow: 55144702.00
BCX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -82411949.00
BCX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 165171370.00
BCX income_statement (annual, 2022-12-31) — General And Administrative Expense: 377799.00
BCX income_statement (annual, 2022-12-31) — Interest Income: 32648.00
BCX balance_sheet (annual, 2022-12-31) — Invested Capital: 983298623.00
BCX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 985383593.00
BCX balance_sheet (annual, 2022-12-31) — Investments And Advances: 985383593.00
BCX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
BCX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 117583.00
BCX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -68354.00
BCX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -6850455.00
BCX balance_sheet (annual, 2022-12-31) — Net Debt: 78180.00
BCX income_statement (annual, 2022-12-31) — Net Income: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 137510755.00
BCX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 137510755.00
BCX income_statement (annual, 2022-12-31) — Net Interest Income: 32648.00
BCX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -68354.00
BCX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -68354.00
BCX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
BCX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 983181040.00
BCX income_statement (annual, 2022-12-31) — Normalized Income: 137510755.00
BCX cash_flow (annual, 2022-12-31) — Operating Cash Flow: 55144702.00
BCX income_statement (annual, 2022-12-31) — Operating Revenue: 140210842.00
BCX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 87518484.00
BCX income_statement (annual, 2022-12-31) — Other Operating Expenses: 2322288.00
BCX balance_sheet (annual, 2022-12-31) — Other Payable: 2016645.00
BCX balance_sheet (annual, 2022-12-31) — Payables: 2190165.00
BCX income_statement (annual, 2022-12-31) — Pretax Income: 137510755.00
BCX balance_sheet (annual, 2022-12-31) — Receivables: 6756837.00
BCX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -68354.00
BCX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -6850455.00
BCX balance_sheet (annual, 2022-12-31) — Retained Earnings: -92923999.00
BCX income_statement (annual, 2022-12-31) — Selling General And Administration: 377799.00
BCX balance_sheet (annual, 2022-12-31) — Share Issued: 87518484.00
BCX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 983181040.00
BCX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 983181040.00
BCX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BCX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
BCX balance_sheet (annual, 2022-12-31) — Total Assets: 992209833.00
BCX balance_sheet (annual, 2022-12-31) — Total Capitalization: 983298623.00
BCX balance_sheet (annual, 2022-12-31) — Total Debt: 117583.00
BCX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 983181040.00
BCX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 9028793.00
BCX income_statement (annual, 2023-12-31) — +Operating Expense: 2277226.00
BCX income_statement (annual, 2023-12-31) — +Total Revenue: -6360710.00
BCX balance_sheet (annual, 2023-12-31) — Accounts Payable: 0.00
BCX balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 20310546.00
BCX income_statement (annual, 2023-12-31) — Basic Average Shares: 84363295.00
BCX income_statement (annual, 2023-12-31) — Basic EPS: -0.04
BCX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 69403.00
BCX balance_sheet (annual, 2023-12-31) — Capital Stock: 1017257473.00
BCX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 11244.00
BCX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 11244.00
BCX cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -53560583.00
BCX balance_sheet (annual, 2023-12-31) — Cash Financial: 11244.00
BCX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -87879.00
BCX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
BCX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 6147790.00
BCX cash_flow (annual, 2023-12-31) — Change In Payable: -127235.00
BCX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 0.00
BCX cash_flow (annual, 2023-12-31) — Change In Receivables: 137863.00
BCX cash_flow (annual, 2023-12-31) — Change In Working Capital: 6070539.00
BCX cash_flow (annual, 2023-12-31) — Changes In Cash: -58149.00
BCX balance_sheet (annual, 2023-12-31) — Common Stock: 1017257473.00
BCX cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -53560583.00
BCX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 891338492.00
BCX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
BCX cash_flow (annual, 2023-12-31) — Common Stock Payments: -30516383.00
BCX balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 10021060.00
BCX income_statement (annual, 2023-12-31) — Diluted Average Shares: 84363295.00
BCX income_statement (annual, 2023-12-31) — Diluted EPS: -0.04
BCX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8637936.00
BCX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -10.00
BCX cash_flow (annual, 2023-12-31) — End Cash Position: 11244.00
BCX balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 886715569.00
BCX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -84194549.00
BCX cash_flow (annual, 2023-12-31) — Free Cash Flow: 84136400.00
BCX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 86703797.00
BCX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 33924124.00
BCX income_statement (annual, 2023-12-31) — General And Administrative Expense: 457037.00
BCX income_statement (annual, 2023-12-31) — Interest Expense: 2847.00
BCX income_statement (annual, 2023-12-31) — Interest Income: 0.00
BCX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 907026115.00
BCX balance_sheet (annual, 2023-12-31) — Investments And Advances: 907026115.00
BCX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
BCX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -30516383.00
BCX income_statement (annual, 2023-12-31) — Net Income: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8637936.00
BCX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8637936.00
BCX income_statement (annual, 2023-12-31) — Net Interest Income: -2847.00
BCX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -117583.00
BCX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -117583.00
BCX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
BCX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 891338492.00
BCX income_statement (annual, 2023-12-31) — Normalized Income: -8637936.00
BCX cash_flow (annual, 2023-12-31) — Operating Cash Flow: 84136400.00
BCX income_statement (annual, 2023-12-31) — Operating Revenue: -6360710.00
BCX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 84363295.00
BCX income_statement (annual, 2023-12-31) — Other Operating Expenses: 1820189.00
BCX balance_sheet (annual, 2023-12-31) — Other Payable: 1166432.00
BCX balance_sheet (annual, 2023-12-31) — Payables: 1166432.00
BCX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 0.00
BCX income_statement (annual, 2023-12-31) — Pretax Income: -8637936.00
BCX balance_sheet (annual, 2023-12-31) — Receivables: 1667875.00
BCX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -30516383.00
BCX balance_sheet (annual, 2023-12-31) — Retained Earnings: -125918981.00
BCX income_statement (annual, 2023-12-31) — Selling General And Administration: 457037.00